UNIVERSITY OF LOUISIANA AT MONROE
Synthetic Somatostatin Analogs Protect Against Endothelial Barrier Dysfunction
Synthetic Somatostatin Analogs Protect Against Endothelial Barrier Dysfunction is a funding opportunity from UNIVERSITY OF LOUISIANA AT MONROE, up to 72500, closing March 31, 2027.
Mar 31, 2027
(243d left)Overview
Summary Endothelial barrier dysfunction (EBD) has been associated with crucial lung injury ((e.g. acute respiratory distress syndrome (ARDS)) and deaths in the Intensive Care Units. Approved medicine that specifically targets EBD does not exist, hence the development of efficient medical countermeasures in that…